RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC.
Healthcare · Market cap: $4.6M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $60.5K | $0 |
| 2022-Q3 | $83.0K | $0 |
| 2022-Q4 | $14.1K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$157.6K3 buy days
Sold$00 sell days
Net insider flow+$157.6Knet buying · 5 years
Latest trade2022-11-18Patel Purav
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2022-11-18 | Buy | Patel Purav | Director | 3,000 | $4.69 | $14.1K | 1 |
| 2022-09-30 | Buy | Narayan Prabhu | CFO | 50,000 | $1.66 | $83.0K | 1 |
| 2022-06-30 | Buy | Narayan Prabhu | CFO | 50,000 | $1.21 | $60.5K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Narayan Prabhu | CFO | $143.5K | $0 | 2022-09-30 |
| Patel Purav | Director | $14.1K | $0 | 2022-11-18 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2018-08-23 → 2018-08-30 | 3 | $10.3M | 53 | – | – | – | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.